BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10965891)

  • 1. Secretion of a lactone-hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells.
    Qazzaz HM; El-Masri MA; Valdes R
    Endocrinology; 2000 Sep; 141(9):3200-9. PubMed ID: 10965891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors.
    el-Masri MA; Clark BJ; Qazzaz HM; Valdes R
    Clin Chem; 2002 Oct; 48(10):1720-30. PubMed ID: 12324489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension.
    Ferrandi M; Manunta P; Rivera R; Bianchi G; Ferrari P
    Clin Exp Hypertens; 1998; 20(5-6):629-39. PubMed ID: 9682919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
    Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
    Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
    Meyer-Lehnert H; Bäcker A; Kramer HJ
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.
    Ferrandi M; Manunta P; Balzan S; Hamlyn JM; Bianchi G; Ferrari P
    Hypertension; 1997 Oct; 30(4):886-96. PubMed ID: 9336389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues.
    Qazzaz HM; Jortani SA; Poole JM; Valdes R
    Clin Chem; 1996 Jul; 42(7):1092-9. PubMed ID: 8674194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous isolation of endogenous digoxin-like immunoreactive factor, ouabain-like factor, and deglycosylated congeners from mammalian tissues.
    Qazzaz HM; Valdes R
    Arch Biochem Biophys; 1996 Apr; 328(1):193-200. PubMed ID: 8638930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular mechanisms of action of a ouabain-like factor in vascular smooth-muscle cells.
    Meyer-Lehnert H; Wanning C; Michel H; Bäcker A; Kramer HJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S16-9. PubMed ID: 7508017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two biologically active isomers of dihydroouabain isolated from a commercial preparation.
    Qazzaz HM; El-Masri MA; Stolowich NJ; Valdes R
    Biochim Biophys Acta; 1999 Nov; 1472(3):486-97. PubMed ID: 10564763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue.
    Qazzaz HM; Goudy SL; Valdes R
    J Biol Chem; 1996 Apr; 271(15):8731-7. PubMed ID: 8621507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian cardenolides in cancer prevention and therapeutics.
    Al-Ghoul M; Valdes R
    Ther Drug Monit; 2008 Apr; 30(2):234-8. PubMed ID: 18367987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of an endogenous ouabain-like immunoreactive compound with digitalis-like properties in the human.
    Balzan S; Montali U; Ghione S
    Ann N Y Acad Sci; 1997 Nov; 834():626-30. PubMed ID: 9405875
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of ouabain-like factor in normal and ischemic rat heart.
    D'Urso G; Frascarelli S; Balzan S; Zucchi R; Montali U
    J Cardiovasc Pharmacol; 2004 May; 43(5):657-62. PubMed ID: 15071352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of endogenous digitalis-like immunoreactive factors in human blood.
    Lin MH; Liao CP; Lee JS; Chin YW; Hsu CC; Wei JS
    Proc Natl Sci Counc Repub China B; 1998 Jul; 22(3):129-35. PubMed ID: 9779602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous immunoreactive ouabain-like and digoxin-like factors in reduced renal mass hypertensive rats.
    Takada T; Nakagawa M; Ura N; Kaide J; Yoshida H; Shimamoto K
    Hypertens Res; 1998 Sep; 21(3):193-9. PubMed ID: 9786604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endogenous digitalis-like factor].
    Yamazato M; Muratani H; Fukiyama K
    Nihon Rinsho; 1997 Aug; 55(8):1971-6. PubMed ID: 9284409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.